AR032573A1 - PIRROLO NUCLEOSIDE ANALOG [2,3-D] PYRIMIDINE - Google Patents

PIRROLO NUCLEOSIDE ANALOG [2,3-D] PYRIMIDINE

Info

Publication number
AR032573A1
AR032573A1 ARP020100590A ARP020100590A AR032573A1 AR 032573 A1 AR032573 A1 AR 032573A1 AR P020100590 A ARP020100590 A AR P020100590A AR P020100590 A ARP020100590 A AR P020100590A AR 032573 A1 AR032573 A1 AR 032573A1
Authority
AR
Argentina
Prior art keywords
group
aralkyl
alkynyl
alkenyl
alkyl
Prior art date
Application number
ARP020100590A
Other languages
Spanish (es)
Original Assignee
Ribapharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribapharm Inc filed Critical Ribapharm Inc
Priority to ARP020100590A priority Critical patent/AR032573A1/en
Publication of AR032573A1 publication Critical patent/AR032573A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un análogo de nucleosido de acuerdo con la formula (1) en donde: A es O, S o CH2; X es H, NH2 u OH; Y es H, halogeno o NH2; C* se dirige a la orientacion beta y es un átomo de carbono secundario unido covalentemente a un átomo de oxígeno o átomo de fosforo; Z se selecciona del grupo que consiste de H, halogeno, R, OH, OR, SH, SR, NH2, NHR, NR2, CN, C(O)NH2, COOH, COOR, CH2NH2, C(=NOH)NH2 y C(=NH)NH2, en donde R es alquilo, alquenilo, alquinilo o aralquilo; R2 y R3 se seleccionan independientemente del grupo que consiste de H, F y OH; R4 se selecciona del grupo que consiste de un hidrogeno, un alquilo, un alquenilo, un alquinilo, y un aralquilo, en donde R4 tiene opcionalmente por lo menos un heteroátomo y un grupo funcional; R5 es OH, OP(O)(OH)2, P(O)(OH)2, OP(O)(OR')2, o P(O)(OR')2, en donde R' es un grupo de enmascaramiento; y R5' se selecciona del grupo que consiste de un alquilo, un alquenilo, un alquinilo, y un aralquilo, en donde R5' posee por lo menos dos átomos de carbono, y por lo menos posee opcionalmente un heteroátomo y un grupo funcional. Utiles en terapias anticáncer, antiviral y enfermedades autoinmunes.A nucleoside analog according to formula (1) wherein: A is O, S or CH2; X is H, NH2 or OH; Y is H, halogen or NH2; C * is directed to the beta orientation and is a secondary carbon atom covalently bonded to an oxygen atom or phosphorus atom; Z is selected from the group consisting of H, halogen, R, OH, OR, SH, SR, NH2, NHR, NR2, CN, C (O) NH2, COOH, COOR, CH2NH2, C (= NOH) NH2 and C (= NH) NH2, where R is alkyl, alkenyl, alkynyl or aralkyl; R2 and R3 are independently selected from the group consisting of H, F and OH; R4 is selected from the group consisting of a hydrogen, an alkyl, an alkenyl, an alkynyl, and an aralkyl, wherein R4 optionally has at least one heteroatom and a functional group; R5 is OH, OP (O) (OH) 2, P (O) (OH) 2, OP (O) (OR ') 2, or P (O) (OR') 2, where R 'is a group masking; and R5 'is selected from the group consisting of an alkyl, an alkenyl, an alkynyl, and an aralkyl, wherein R5' possesses at least two carbon atoms, and at least optionally possesses a heteroatom and a functional group. Useful in anticancer, antiviral and autoimmune diseases.

ARP020100590A 2002-02-21 2002-02-21 PIRROLO NUCLEOSIDE ANALOG [2,3-D] PYRIMIDINE AR032573A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP020100590A AR032573A1 (en) 2002-02-21 2002-02-21 PIRROLO NUCLEOSIDE ANALOG [2,3-D] PYRIMIDINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP020100590A AR032573A1 (en) 2002-02-21 2002-02-21 PIRROLO NUCLEOSIDE ANALOG [2,3-D] PYRIMIDINE

Publications (1)

Publication Number Publication Date
AR032573A1 true AR032573A1 (en) 2003-11-12

Family

ID=37516290

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100590A AR032573A1 (en) 2002-02-21 2002-02-21 PIRROLO NUCLEOSIDE ANALOG [2,3-D] PYRIMIDINE

Country Status (1)

Country Link
AR (1) AR032573A1 (en)

Similar Documents

Publication Publication Date Title
BG95575A (en) 3'-(2')-AMINO-AND THIOL-MODIFIED, LINKED TO FLUORESCENT DYE NUCLEOSIDES, NUCLEOTIDES AND OLIGONUCLEOTIDES AND METHOD FOR THEIR PREPARATION AND APPLICATION
TR200402300T4 (en) Imidazopyrimidine derivatives and triazolopyrimidine derivatives.
ES2181208T3 (en) ANTIVIRAL PYRIMIDINE NUCLEOSID ANALOGS.
DE69733674D1 (en) PURINMER OF CYCLIN-DEPENDENT KINASE 2 AND IkappaB-alpha
DE69911448D1 (en) PYRAZOLOPYRIMIDINONE, CGMP PDE5 INHIBITORS, FOR THE TREATMENT OF SEXUAL FUNCTIONAL DISORDERS
RU2000129663A (en) NEW NUCLEOSIDES HAVING Bicyclic Sugar Grouping
HUP0301614A2 (en) Pyrido[2,3-d]pyrimidini and pyrimido[4,5-d]pyrimidini nucleosides
NZ298296A (en) Imidazo[4,5-c]quinoline amines; medicaments to induce interferon biosynthesis
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
BR0011521B1 (en) 4-C-Ethinyl Purine Nucleoside Compounds
NZ513402A (en) Novel nucleosides and oligonucleotide analogues
EP0287313A3 (en) Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus
ATE134644T1 (en) OTHER ANTIVIRAL PYRIMIDINE NUCLEOSIDES
ES2104570T3 (en) ANALOGS OF NUCLEOTIDES.
DE60101223D1 (en) ANTIVIRAL PYRIMIDINE NUCLEOSIDE DERIVATIVES
FI965020A (en) New compounds, methods for their preparation and antitumor agents
ATE327242T1 (en) NEW PURINES
EP0701562A1 (en) Unsaturated phosphonates derivatives of purines and pyrimidines
AR032573A1 (en) PIRROLO NUCLEOSIDE ANALOG [2,3-D] PYRIMIDINE
RO84661B (en) Process for preparing oxazaphosphorin/4-thioalkane-sulphonic acid or neutral salts thereof
BR9711936A (en) Composition of urea grease and gears
TR200102501T2 (en) Antiviral nucleoside analogs.
ES8501416A1 (en) Nucleoside 5'-alkyl- or alkenylphosphate.
GR3003738T3 (en)
ES476645A1 (en) Amino derivatives of pyrazolo [1,5-a]s-triazine, and their therapeutic applications

Legal Events

Date Code Title Description
FB Suspension of granting procedure